UK Studies More Antibody And Viral Test Options In COVID-19 Control Program
Executive Summary
While COVID-19 testing capacity rises slowly the in UK, the scientific community is pressing to develop the range of test types to get the numbers up further to secure sustainable control of the disease.
You may also be interested in...
UK Still Looking For The Magic Bullet To Reach COVID-19 Testing Goals
Viral testing of swabs using PCR to confirm COVID-19 in individuals continues to be the main thrust of the UK’s coronavirus control efforts as it targets 100,000 and more tests a day. PCR alternatives and antibody testing will come into the picture more in the coming weeks.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.